SGH
NUVA

Sivik Global Healthcare’s NuVasive, Inc. NUVA Stock Holding History

Sivik Global Healthcare’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-45,100
Closed -$2.19M – 45
2020
Q3 		$2.19M Buy
+45,100
New +$2.43M 0.94% 37
2015
Q1 		– Sell
-40,700
Closed -$1.92M – 81
2014
Q4 		$1.92M Buy
+40,700
New +$1.7M 0.78% 53

Other funds holding NUVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Sivik Global Healthcare's NUVA Position: Q4 2020 in Review

Sivik Global Healthcare sold out of NuVasive, Inc. (NUVA) in Q4 2020, closing a stake of 45,100 shares — an estimated $2.19M sold.

Sivik Global Healthcare first reported a position in NUVA in Q4 2014 and held it in 2 quarters. The position peaked at $2.19M in Q3 2020. 280 funds tracked by Wall St. Rank hold NUVA as of Q4 2020.

  • Sivik Global Healthcare reported no remaining NuVasive, Inc. position as of Q4 2020 after selling out during the quarter.
  • Sivik Global Healthcare sold 45,100 NuVasive, Inc. shares in Q4 2020, an estimated $2.19M.
  • Sivik Global Healthcare first reported a position in NuVasive, Inc. in Q4 2014 and held it in 2 quarters.
  • Sivik Global Healthcare's NuVasive, Inc. position peaked at $2.19M in Q3 2020.
  • 280 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2020.

Based on Sivik Global Healthcare's 13F filing for Q4 2020, filed 16 Feb 2021.